Research
Hormonal
Using tirzepatide resulted in a weight loss of 17.8% compared with 12.4% for semaglutide.
Tirzepatide may be more effective for weight loss in patients with type 2 diabetes.
StrongSupportsmedium confidence
Using tirzepatide resulted in a weight loss of 17.8% (95% CI: 16.3%-19.3%) compared with 12.4% (95% CI: 11.5%-13.4%) for semaglutide.
Why this rating
Based on the results from published trials.
Source
Tirzepatide versus semaglutide for weight loss in patients with type 2 diabetes mellitus: A value for money analysis
Joseph Azuri et al. · Diabetes Obesity and Metabolism · 2022
otherCited 41×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →